日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncologically safe minimally invasive management of a 25 cm cystic abdominopelvic mass using contained, controlled drainage and removal

采用肿瘤学上安全的微创方法,通过封闭式、可控的引流和切除术,治疗直径 25 厘米的腹盆腔囊性肿块。

Abozenah, Yasmin; Greenman, Michelle; Goreshnik, Ashley; Altwerger, Gary

Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case

RUBY试验之外的不良事件:在真实世界的子宫内膜癌病例中报告免疫疗法相关的心肌炎、肌炎和重症肌无力

Abozenah, Yasmin; McNamara, Blair; Greenman, Michelle; Daigle, Emily; Mikhaiel, John Paul; DiCapua, Daniel; Kwan, Jennifer; Azodi, Masoud; Altwerger, Gary

HIPEC with cisplatin desensitization at the time of secondary debulking in a patient with a prior carboplatin hypersensitivity reaction

既往有卡铂过敏反应的患者在二次肿瘤细胞减灭术时接受顺铂脱敏治疗的腹腔热灌注化疗(HIPEC)。

Greenman, Michelle; Abozenah, Yasmin; Pan, Yifang Eva; Ratner, Elena S; Altwerger, Gary

Harnessing the effects of hypoxia-like inhibition on homology-directed DNA repair

利用缺氧样抑制作用对同源定向DNA修复的影响

Altwerger, Gary; Ghazarian, Maddie; Glazer, Peter M

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix

子宫颈低分化高级别神经内分泌癌的整合突变图谱分析

Bellone, Stefania; Jeong, Kyungjo; Halle, Mari Kyllesø; Krakstad, Camilla; McNamara, Blair; Greenman, Michelle; Mutlu, Levent; Demirkiran, Cem; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Zipponi, Margherita; Buza, Natalia; Hui, Pei; Raspagliesi, Francesco; Lopez, Salvatore; Paolini, Biagio; Milione, Massimo; Perrone, Emanuele; Scambia, Giovanni; Altwerger, Gary; Ravaggi, Antonella; Bignotti, Eliana; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Quick, Charles M; Angioli, Roberto; Terranova, Corrado; Zaidi, Samir; Nandi, Shuvro; Alexandrov, Ludmil B; Siegel, Eric R; Choi, Jungmin; Schlessinger, Joseph; Santin, Alessandro D

Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

更正:一项随机II期临床试验,研究每周一次伊沙匹隆联合或不联合每两周一次贝伐珠单抗治疗铂类耐药或难治性卵巢癌/输卵管癌/原发性腹膜癌的疗效。

Roque, Dana M; Siegel, Eric R; Buza, Natalia; Bellone, Stefania; Silasi, Dan-Arin; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E; Rao, Gautam G; Reader, Jocelyn C; Hui, Pei; Tymon-Rosario, Joan R; Harold, Justin; Mauricio, Dennis; Zeybek, Burak; Menderes, Gulden; Altwerger, Gary; Ratner, Elena; Santin, Alessandro D

Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients

基因突变对上皮性卵巢癌患者生存结局的预测模型

Ma, Mirielle C; Lavi, Ethan S; Altwerger, Gary; Lin, Z Ping; Ratner, Elena S

Uterine teratoma and the role of short-tandem repeat genotyping in understanding origins

子宫畸胎瘤及短串联重复序列基因分型在理解其起源中的作用

AlAshqar, Abdelrahman; Kadam Maruthi, Vijaya; Abi-Raad, Rita; Greenman, Michelle; Hui, Pei; Ratner, Elena; Altwerger, Gary; Santin, Alessandro; Andikyan, Vaagn

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT03093155): Updated survival and subgroup analyses

一项针对铂类耐药或难治性卵巢癌/输卵管癌/原发性腹膜癌的随机II期试验,比较每周一次伊沙匹隆±每两周一次贝伐珠单抗的疗效(NCT03093155):更新的生存率和亚组分析

Roque, Dana M; Siegel, Eric R; Buza, Natalia; Bellone, Stefania; Huang, Gloria S; Altwerger, Gary; Andikyan, Vaagn; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E; Rao, Gautam G; Ratner, Elena; Santin, Alessandro D

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

曲妥珠单抗德鲁西替康治疗子宫浆液性癌的体内外疗效

Mutlu, Levent; Manavella, Diego D; Bellone, Stefania; McNamara, Blair; Harold, Justin A; Mauricio, Dennis; Siegel, Eric R; Buza, Natalia; Hui, Pei; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z; Altwerger, Gary; Ratner, Elena S; Huang, Gloria S; Clark, Mitchell; Andikyan, Vaagn; Azodi, Masoud; Dottino, Peter R; Schwartz, Peter E; Santin, Alessandro D